Prnewswire·2025-11-21 18:35Core Points - Elanco Animal Health has received Emergency Use Authorization (EUA) from the FDA for Credelio CAT (lotilaner) to treat New World screwworm (NWS) infestations in cats, marking the first EUA for this purpose in felines [1][10] - The EUA is a proactive measure in response to confirmed cases of NWS detected near the U.S.-Mexico border, ensuring treatment options are available for veterinarians and pet owners [2][6] - Elanco emphasizes its commitment to feline health by providing innovative solutions for cats, addressing the historical disparity in treatment options compared to dogs [3][5] Company and Product Information - Credelio CAT is part of Elanco's broader Credelio franchise, which has previously received EUA for treating NWS in dogs, showcasing a comprehensive approach to animal health [5][10] - The FDA's authorization was based on research demonstrating Credelio CAT's efficacy against both Old World and New World screwworms [4][10] - Elanco aims to fill the gap in companion animal care, as only 40% of cat owners take their pets to the veterinarian compared to over 90% of dog owners [3][6] Health and Safety Considerations - The New World screwworm poses a significant threat as it lays eggs on open wounds of healthy animals, leading to severe tissue damage if untreated [6][8] - Preventative measures, such as effective flea and tick control, are crucial to minimize the risk of NWS infestations [7][9] - Credelio CAT is indicated for the treatment and prevention of flea infestations and is effective for cats and kittens aged 8 weeks and older [12][15]